Methyl 4-bromo-2-(bromomethyl)-6-fluorobenzoate, 98%, 250mg

(E)-4-Methoxy-N-(2-(2-(pyridin-4-yl)vinyl)phenyl)benzenesulfonamide, 97.0%, 25mg

N-(4-acetylphenyl)acetamide, 98.0%, 5g

1-(4-Aminopiperidin-1-yl)ethanone hydrochloride, 95.0%, 10g

N-([1,1':3',1''-Terphenyl]-5'-yl)-9,9-dimethyl-9H-fluoren-2-amine>97.0%(HPLC)(N)1g

4,6-DIFLUORO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95.0%, 250mg

2-Butanol, min. 98.5%, for synthesis, 2.5 l, plastic packaging.

N-allyl-3-methyltetrahydro-3-thiophenamine 1,1-dioxide hydrochloride, 95.0%, 10g

Tetrahydropyran-2-methanol>96.0%(GC)25mL

2-Bromo-3,5-dimethylpyridine, 95.0%, 10g

1-isopropyl-3-isothiocyanatobenzene, 95.0%, 5g

4-Methyl-1,2-dihydro-pyridazine-3,6-dione, 97.0%, 10g

1-methyl-4,5,6,7-tetrahydro-1H-benzimidazole, 95.0%, 250mg